Developing A Novel Combinatorial Therapy for Lethal Neuroendocrine Prostate Cancer
Research Grant
Administered By
Pathology
Awarded By
National Cancer Institute
Start Date
August 1, 2022
End Date
July 31, 2027
Administered By
Pathology
Awarded By
National Cancer Institute
Start Date
August 1, 2022
End Date
July 31, 2027